100 related articles for article (PubMed ID: 28285961)
1. Immunocytochemical expression of a panel of markers in pleural effusions from patients with primary lung adenocarcinoma.
Chaini E; Athanassiadou AM; Vassias A; Tsipis A; Gonidi M; Hainis KD; Charpidou A; Athanassiadou P
Pathol Res Pract; 2017 May; 213(5):502-508. PubMed ID: 28285961
[TBL] [Abstract][Full Text] [Related]
2. [Combined detection of thyroid transcription factor 1 and napsin A in pleural fluid cell blocks facilitates cytopathologic diagnosis of pulmonary adenocarcinoma].
Xu X; Liu H; Jiang H; Li C; Yuan S; Yang J
Nan Fang Yi Ke Da Xue Xue Bao; 2015 Nov; 35(11):1610-3. PubMed ID: 26607085
[TBL] [Abstract][Full Text] [Related]
3. High expression of E-cadherin in pleural effusion cells predicts better prognosis in lung adenocarcinoma patients.
Zhao C; Li X; Su C; Li J; Cheng N; Ren S; Chen X; Zhou C
Int J Clin Exp Pathol; 2015; 8(3):3104-9. PubMed ID: 26045824
[TBL] [Abstract][Full Text] [Related]
4. Utility of TTF-1 and Napsin-A in the work-up of malignant effusions.
El Hag M; Schmidt L; Roh M; Michael CW
Diagn Cytopathol; 2016 Apr; 44(4):299-304. PubMed ID: 26799356
[TBL] [Abstract][Full Text] [Related]
5. EMT markers in lung adenocarcinoma pleural effusion spheroid cells.
Giarnieri E; De Vitis C; Noto A; Roscilli G; Salerno G; Mariotta S; Ricci A; Bruno P; Russo G; Laurenzi A; Giovagnoli MR; Ciliberto G; Mancini R
J Cell Physiol; 2013 Aug; 228(8):1720-6. PubMed ID: 23255165
[TBL] [Abstract][Full Text] [Related]
6. Expression and significance of MOC-31 and calretinin in pleural fluid of patients with lung cancer.
Lv M; Leng JH; Hao YY; Sun Y; Cha N; Wu GP
Diagn Cytopathol; 2015 Jul; 43(7):527-31. PubMed ID: 25346242
[TBL] [Abstract][Full Text] [Related]
7. Cell transfer technique for constructing cytological microarrays for immunocytochemical analysis.
Wen CH; Lin CH; Ko PL; Kuo YF; Chen YJ; Chai CY
Cytopathology; 2017 Apr; 28(2):157-163. PubMed ID: 27526949
[TBL] [Abstract][Full Text] [Related]
8. TTF-1 and napsin A on cell blocks and supernatants of pleural fluids for labeling malignant effusions.
Porcel JM; Palma R; Bielsa S; Esquerda A; Gatius S; Matias-Guiu X; Salud A
Respirology; 2015 Jul; 20(5):831-3. PubMed ID: 25873201
[TBL] [Abstract][Full Text] [Related]
9. Napsin A (TA02) is a useful alternative to thyroid transcription factor-1 (TTF-1) for the identification of pulmonary adenocarcinoma cells in pleural effusions.
Dejmek A; Naucler P; Smedjeback A; Kato H; Maeda M; Yashima K; Maeda J; Hirano T
Diagn Cytopathol; 2007 Aug; 35(8):493-7. PubMed ID: 17636482
[TBL] [Abstract][Full Text] [Related]
10. The application and diagnostic utility of immunocytochemistry on direct smears in the diagnosis of pulmonary adenocarcinoma and squamous cell carcinoma.
Roh MH; Schmidt L; Placido J; Farmen S; Fields KL; Courey AJ; Arenberg DA; Knoepp SM
Diagn Cytopathol; 2012 Nov; 40(11):949-55. PubMed ID: 21500373
[TBL] [Abstract][Full Text] [Related]
11. Heterogeneity of cancer stem cell-related marker expression is associated with three-dimensional structures in malignant pleural effusion produced by lung adenocarcinoma.
Lin YY; Lin YS; Liang CW
Cytopathology; 2024 Jan; 35(1):105-112. PubMed ID: 37897199
[TBL] [Abstract][Full Text] [Related]
12. Transcription expression and clinical significance of dishevelled-3 mRNA and δ-catenin mRNA in pleural effusions from patients with lung cancer.
Li XY; Liu SL; Cha N; Zhao YJ; Wang SC; Li WN; Wang EH; Wu GP
Clin Dev Immunol; 2012; 2012():904946. PubMed ID: 22461838
[TBL] [Abstract][Full Text] [Related]
13. Slug regulates E-cadherin expression in metastatic adenocarcinoma cells isolated from pleural fluid.
Li XN; Fang CQ; Wang YL; Wang XR; Wang EH; Li JH
Diagn Cytopathol; 2013 Jan; 41(1):9-14. PubMed ID: 21656704
[TBL] [Abstract][Full Text] [Related]
14. Quality of cell blocks prepared from residual pleural effusion and bronchial washing samples for immunocytochemistry.
Harabajsa S; Milutin L; Breški A; Ražnjević K; Šimić V; Branica BV; Smojver-Ježek S
Cytopathology; 2023 May; 34(3):264-270. PubMed ID: 36941745
[TBL] [Abstract][Full Text] [Related]
15. Thyroid transcription factor 1 and napsin a double staining in lung adenocarcinoma in pleural fluid.
Liu L; Cohen C; Siddiqui MT
Acta Cytol; 2012; 56(4):425-30. PubMed ID: 22846220
[TBL] [Abstract][Full Text] [Related]
16. Alteration of the E-cadherin/β-catenin complex predicts poor response to epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI) treatment.
Yoo SB; Kim YJ; Kim H; Jin Y; Sun PL; Jheon S; Lee JS; Chung JH
Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S545-52. PubMed ID: 23579873
[TBL] [Abstract][Full Text] [Related]
17. Transcription expression and clinical significance of TTF-1 mRNA in pleural effusion of patients with lung cancer.
Jiang B; Wu GP; Zhao YJ; Wang SC
Diagn Cytopathol; 2008 Dec; 36(12):849-54. PubMed ID: 18855882
[TBL] [Abstract][Full Text] [Related]
18. Utility of thyroid transcription factor-1 and CDX-2 in determining the primary site of metastatic adenocarcinomas in serous effusions.
Kim JH; Choi YD; Lee JS; Lee JH; Nam JH; Choi C
Acta Cytol; 2010; 54(3):277-82. PubMed ID: 20518411
[TBL] [Abstract][Full Text] [Related]
19. EGFR mutations predict a favorable outcome for malignant pleural effusion of lung adenocarcinoma with Tarceva therapy.
Guo H; Wan Y; Tian G; Liu Q; Kang Y; Li Y; Yao Z; Lin D
Oncol Rep; 2012 Mar; 27(3):880-90. PubMed ID: 22134479
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic value of tumor markers for lung adenocarcinoma-associated malignant pleural effusion: a validation study and meta-analysis.
Feng M; Zhu J; Liang L; Zeng N; Wu Y; Wan C; Shen Y; Wen F
Int J Clin Oncol; 2017 Apr; 22(2):283-290. PubMed ID: 27990560
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
